Among the life science current events from last week: an incubator using Mayo Clinic technologies crumbles, a health IT firm wins FDA approval, an Israeli radiation monitoring technology wins FDA approval, and a blood clot treatment earns orphan drug designation.
Investing in healthcare is harder than it seems, even when you have the Mayo Clinic name behind you. Minnesota incubator Health IP Partners was created to commercialize technology from Mayo Clinic and similar institutions. But it is shutting down after less than two years. The organization, among other things, improperly leveraged Mayo's name for fundraising purposes.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.